|Articles|September 9, 2010

Regulatory Roundup: ICH to Hold Training Workshops for Quality Guidelines

ICH to Hold Training Workshops for Quality Guidelines

The International Conference on Harmonization’s Implementation Working Group (IWG) for the quality guidelines, Q8 Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System, is holding a series of training workshops. The US workshop is being held in Bethesda, Maryland, Oct. 6–8, 2010. The International Society for Pharmaceutical Engineering (ISPE) and Parenteral Drug Association (PDA) are sponsoring the workshop, which is meant to help industry understand how the quality trio can benefit pharmaceutical development, manufacturing, regulatory assessment, scale up to commercial operations, and GMP inspection. Regulators from various countries and regions will be presenting at the meeting. Four breakout discussions will address design space, control strategy, the pharmaceutical quality system, and quality risk management. Feedback from workshop participants will help IWG with harmonization efforts.


Related to this article

PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.